Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Belani

Showing results (41-50 of 298) with videos related to

Pageof 30
Sort By:
Lung Cancer (Amsterdam, Netherlands)|February 9, 2005
Integration of docetaxel in the management of non-small-cell lung cancerChandra P Belani
Lung Cancer (Amsterdam, Netherlands)|December 14, 2002
First-line chemotherapy for NSCLC: an overview of relevant trialsChandra P Belani, Corey Langer,
Clinical Lung Cancer|February 18, 2004
Cyclooxygenase-2 inhibitors in lung cancerSakkaraiappan Ramalingam, Chandra P Belani
Hematology/Oncology Clinics of North America|March 10, 2004
Basic treatment considerations: chemotherapySakkaraiappan Ramalingam, Chandra P Belani
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1992
Combined-modality therapies for non-small cell lung cancerC P Belani, J Aisner
Clinical Lung Cancer|April 23, 2005
Bevacizumab extends survival for patients with nonsquamous non-small-cell lung cancerChandra P Belani, Sakkaraiappan Ramalingam
Oncology (Williston Park, N.Y.)|September 2, 2004
Carboplatin/gemcitabine combination in advanced NSCLCSakkaraiappan Ramalingam, Chandra P Belani
Seminars in Oncology|June 1, 1994
Combined chemotherapy and radiation in locally advanced non-small cell lung cancerC P Belani, J Aisner
The Oncologist|December 22, 2005
Optimizing first-line treatment options for patients with advanced NSCLCHeather Wakelee, Chandra P Belani
Expert Opinion on Pharmacotherapy|December 1, 2005
Molecularly-targeted therapies for non-small cell lung cancerSuresh Ramalingam, Chandra P Belani
Pageof 30

Showing results (41-50 of 298) with videos related to

Sort By:
Pageof 30
Lung Cancer (Amsterdam, Netherlands)|February 9, 2005
Integration of docetaxel in the management of non-small-cell lung cancerChandra P Belani
Lung Cancer (Amsterdam, Netherlands)|December 14, 2002
First-line chemotherapy for NSCLC: an overview of relevant trialsChandra P Belani, Corey Langer,
Clinical Lung Cancer|February 18, 2004
Cyclooxygenase-2 inhibitors in lung cancerSakkaraiappan Ramalingam, Chandra P Belani
Hematology/Oncology Clinics of North America|March 10, 2004
Basic treatment considerations: chemotherapySakkaraiappan Ramalingam, Chandra P Belani
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1992
Combined-modality therapies for non-small cell lung cancerC P Belani, J Aisner
Clinical Lung Cancer|April 23, 2005
Bevacizumab extends survival for patients with nonsquamous non-small-cell lung cancerChandra P Belani, Sakkaraiappan Ramalingam
Oncology (Williston Park, N.Y.)|September 2, 2004
Carboplatin/gemcitabine combination in advanced NSCLCSakkaraiappan Ramalingam, Chandra P Belani
Seminars in Oncology|June 1, 1994
Combined chemotherapy and radiation in locally advanced non-small cell lung cancerC P Belani, J Aisner
The Oncologist|December 22, 2005
Optimizing first-line treatment options for patients with advanced NSCLCHeather Wakelee, Chandra P Belani
Expert Opinion on Pharmacotherapy|December 1, 2005
Molecularly-targeted therapies for non-small cell lung cancerSuresh Ramalingam, Chandra P Belani
Pageof 30